The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis;
pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental …

Annexin A5 (AnxA5) binds to phospholipid bilayers, forming two-dimensional crystals that
block the phospholipids from availability for coagulation enzyme reactions. Antiphospholipid …

See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary
Background: The characteristics and the clinical course of antiphospholipid syndrome (APS) …

Background: The antiphospholipid syndrome (APS) is an important cause of acquired
thromboembolic complications and pregnancy morbidity. Its diagnosis is based on clinical …

The updated Sapporo classification criteria for antiphospholipid syndrome (APS) only
include thrombosis or pregnancy morbidity as clinical criteria. To test this notion, we studied …

Background The clinical utility of testing for antiphospholipid antibodies (aPL) of IgA isotype
remains controversial. Methodology/Principal Findings To address this issue, we reasoned …

Background: Anticardiolipin (aCL) and anti‐β 2 glycoprotein I (aβ 2 GPI) antibodies are part
of the criteria for antiphospholipid syndrome (APS). Therefore they are widely measured and …

Persistently positive antiphospholipid antibodies in association with thromboses and/or
pregnancy morbidity is the hallmark of the antiphospholipid syndrome. The management of …

According to the classification criteria of antiphospholipid syndrome, lupus anticoagulant,
anticardiolipin and anti-β2 glycoprotein I antibody assays are independent risk factors for the …

Antiphospholipid syndrome (APS) is diagnosed in the presence of vascular thrombosis or
pregnancy morbidity occurring in patients with circulating antiphospholipid antibodies (lupus …